The six-year-old suffers from Dravet syndrome
- a rare condition which means she suffers countless seizures daily.
The analyst's research makes him optimistic regarding the path for Zogenix to extend the exclusivity period of ZX008 in Dravet syndrome
beyond the consensus expectation of seven-and-a-half years of orphan/pediatric drug exclusivities.
Mrs Price said: "Corey has Dravet Syndrome
, a type of epilepsy.
United States-based Zogenix has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for its investigational product, ZX008 (low-dose fenfluramine) intended for the treatment of seizures associated with Dravet syndrome
, it was reported yesterday.
I was moved by Jun and Myca Yutuc, the parents of Moon Jaden who was suffering from Dravet Syndrome
Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome
Now, there is evidence whether marijuana can be helpful in treating epilepsy and control seizures, also in difficult to control conditions like Lennox-Gastaut syndrome (LGS) in children and adults as well as Dravet syndrome
After MRIs and other tests drew a blank, Joshua has only recently been diagnosed with Dravet syndrome
, thought to affect around one in every 300 epilepsy sufferers.
The study, published in The New England Journal of Medicine, focused on Dravet syndrome
, a severe form of epilepsy beginning in infancy that is associated with drug-resistant seizures and a high mortality rate.
The cannabidiol compound reduced convulsive seizures by nearly 40% in teenagers and children with Dravet syndrome
, a rare and severe epileptic condition that does not respond to traditional drug treatments.
This not only paid for Thomas' equipment but also left funds over which are being donated to a charity for Dravet Syndrome
- which Thomas has been diagnosed with - a rare genetic brain condition.
Epidiolex (CBD) orphan epilepsy program in Dravet syndrome
, Lennox-Gastaut Syndrome (LGS), Tuberous Sclerosis Complex (TSC) and infantile spasms (IS) Regulatory: NDA submission for both Dravet and LGS indications expected mid-2017 Expected EU regulatory submission in H2 2017 Rare pediatric disease designation conditionally granted by FDA pre-cursor to priority review voucher Orphan Designation granted by European Medicines Agency (EMA) in the treatment of LGS.